-
World's Biggest Vaccine Producer Lends Support to AstraZeneca After Drugmaker Misstep
Saturday, November 28, 2020 - 4:28pm | 492Read More...Serum Institute of India (SII), which has partnered with Novavax, Inc (NASDAQ: NVAX) and AstraZeneca Plc (NYSE: AZN) for trials in India, believes the latter’s COVID-19 vaccine is “a very good one.” What Happened: SII Chief Executive Adar Poonawalla praised the efficiency of...
-
Here's How Much Investing $1,000 In Major Coronavirus Vaccine Developers Before Their Announcements Would Fetch
Friday, November 27, 2020 - 9:21am | 993Read More...Stocks with a COVID-19 vaccine angle have made significant gains on developmental milestones, and in some cases have shown what is arguably irrational exuberance. Irrational Exuberance Or Thought-Out Strategy? The rally seen in vaccine developers has come despite skepticism regarding the...
-
Moderna Finalizes European Supply Deal For Up To 160M COVID-19 Vaccine Doses
Wednesday, November 25, 2020 - 2:29pm | 370Read More...Moderna Inc (NASDAQ: MRNA) shares were advancing Wednesday after the announcement of a vaccine supply deal with the European Commission. What Happened: The Cambridge, Massachusetts-based biopharma said the European Commission has approved an agreement for the company to supply 80 million...
-
Pharma Sector Did Its Job With COVID-19 Vaccine: Barclays Analyst
Friday, November 20, 2020 - 3:54pm | 471Read More...The pharmaceutical industry has succeeded in doing its job in manufacturing multiple vaccines for the novel coronavirus, and it's "now in the hands" of government authorities to manage the distribution, Emily Field, head of European pharmaceutical research at Barclays, Emily...
-
BofA Upgrades United Rentals, Says COVID Vaccine A Potential 'Cure' For Industry
Friday, November 20, 2020 - 11:00am | 296Read More...A potential vaccine against COVID-19 is a potential "cure" for non-residential equipment rental companies like United Rentals, Inc. (NYSE: URI), according to BofA Securities. The United Rentals Analyst: Ross Gilardi upgraded United Rentals' stock from Neutral to Buy with a price...
-
Pfizer, BioNTech File First For Emergency Use Authorization Of Coronavirus Vaccine
Friday, November 20, 2020 - 8:36am | 477Read More...Signaling that Pfizer Inc. (NYSE: PFE) and BioNTech SE – ADR (NASDAQ: BNTX) are nearing the finish line, the companies announced plans Friday to apply for emergency use authorization for the coronavirus vaccine candidate BNT162b2. First To File: The filing means the...
-
COVID Vaccine Logistics To Start As Sprint, Turn Into Marathon
Thursday, November 19, 2020 - 10:31am | 1691Read More...About 40 million doses of two leading COVID-19 vaccines could be available for nationwide distribution by the end of December, with similar amounts metered out each month afterward in a carefully synchronized manner to ensure all jurisdictions have a predictable supply, Operation Warp Speed...
-
Pharma Supply Chain Faces Challenges, Even Before COVID Vaccine Distribution
Wednesday, November 18, 2020 - 9:52am | 1319Read More...Distribution of a COVID-19 vaccine will be the prime objective for many in the pharmaceutical supply chain in 2021, but based on a new survey, concerns about the state of the supply chain could slow effective and timely distribution. And it goes beyond the expected issues with the temperature-...
-
Pfizer's Pilot Program For Vaccine Distribution In 4 States: What You Should Know
Tuesday, November 17, 2020 - 3:54pm | 506Read More...Pfizer, Inc. (NYSE: PFE) shares, which came under selling pressure Monday in response to positive news on a rival vaccine candidate from Moderna, Inc. (NASDAQ: MRNA), were rebounding Tuesday after Pfizer unveiled an action plan to distribute its COVID-19 vaccine candidate upon successful regulatory...
-
Tulane Professor Offers Personal Account Of COVID-19 Vaccine Trial
Tuesday, November 17, 2020 - 11:41am | 321Read More...Tulane University history professor Walter Isaacson was one of 44,000 individuals to participate in Pfizer Inc.'s (NYSE: PFE) COVID-19 vaccine trial, and the process was "pretty easy," he said during a Tuesday morning Fox Business interview. 'Citizen Science' In Vaccine Trials...
-
Fintech Focus For November 17, 2020
Monday, November 16, 2020 - 6:48pm | 2009Read More...Quote Of The Day: Let us always meet each other with a smile, for the smile is the beginning of love. - Mother Teresa Fintech Movers: So far, in 2020 (January to October), FinTechs have raised approximately $35.69 billion compared to the $37.07 billion raised in the same period in 2019. - MEDICI...
-
2 COVID-19 Vaccine Plays You May Not Know
Monday, November 16, 2020 - 5:29pm | 358Read More...Think it’s too late to get in and profit on the vaccine rally? It might not be. Pfizer (NYSE: PFE), BioNTech (NASDAQ: BNTX) and Moderna (NASDAQ: MRNA) all recently announced positive data from their respective vaccine trials and rallied, but other companies could be traded on...
-
Bloomin' Brands Has 40% Upside Potential, BMO Says
Monday, November 16, 2020 - 2:00pm | 366Read More...Outback Steakhouse's parent company Bloomin' Brands Inc (NASDAQ: BLMN) faces a few months of challenges ahead but could be a winner in the restaurant category in a post-COVID reality, according to BMO Capital Markets. The Analyst: Andrew Strelzik upgraded Bloomin' Brands stock from...
-
NYC Restaurant Lobby Group Implores Cuomo To 'Publicly Justify' New Curfew
Thursday, November 12, 2020 - 4:20pm | 413Read More...New York Gov. Andrew Cuomo announced new restrictions that will impact the hospitality industry, and the NYC Hospitality Alliance wants the government's decision to be "publicly justified" with data. New York Curfews: Cuomo announced statewide restrictions that are effective...
-
7 Stocks That Could Benefit From Pfizer's COVID-19 Vaccine That Requires Cold Chain Storage
Thursday, November 12, 2020 - 3:55pm | 676Read More...Pfizer Inc.'s (NYSE: PFE) coronavirus vaccine candidate may have turned in strong efficacy results, but the logistics it requires could impact the vaccine's eventual uptake. Opportunity In Adversity: The mRNA vaccine jointly developed by Pfizer and BioNTech SE – ADR (NASDAQ:...
